Manipal Health Enterprises IPO to Open on July 29, 2026 - Check Price Band, Issue Size, Timeline & Key Details

Manipal Health Enterprises is set to open its Initial Public Offering (IPO) for subscription on July 29, 2026. According to the Red Herring Prospectus (RHP), the ₹9,273.64 crore IPO comprises a fresh issue of up to ₹7,998.43 crore and an Offer for Sale (OFS) of up to ₹1,275.22 crore by existing shareholders.

The IPO will be available for subscription from Wednesday, July 29, 2026, to Friday, July 31, 2026, with anchor investor bidding scheduled for Tuesday, July 28, 2026. The basis of allotment is expected to be finalised on August 3, 2026, and the shares are tentatively scheduled to be listed on both the NSE and BSE on August 5, 2026.

Manipal Health Enterprises IPO - Issue Details

• Issue Type: Book Built Issue (Fresh Issue + OFS)
• Total Issue Size: Up to ₹9,273.64 crore
• Fresh Issue: Up to ₹7,998.43 crore
• Offer for Sale (OFS): Up to ₹1,275.22 crore
• Face Value: ₹2 per equity share
• Price Band: ₹560 to ₹590 per share
• Lot Size: 25 shares
• Minimum Investment Amount (Retail Investor): ₹14,750 (25 shares at the upper price band)
• Listing: BSE, NSE
• Book Running Lead Managers:  Kotak Mahindra Capital Company Limited, Axis Capital Limited, Goldman Sachs (India) Securities Private Limited, Jefferies India Private Limited, J.P. Morgan India Private Limited, UBS Securities India Private Limited and DBS Bank India Private Limited
• Registrar: KFin Technologies Limited

Manipal Health Enterprises IPO Timeline (Tentative)

The expected IPO schedule is as follows:

Note: The allotment and listing dates are tentative and may be revised.

Explore other Upcoming IPOs on BSE and NSE.

Manipal Health Enterprises IPO Category-wise Investment Limits

The application size for each category is as follows -

The minimum investment amount for each category, based on the upper price band of ₹590 per share, is as follows -

Utilisation of IPO Proceeds

The company intends to utilise the net proceeds from the fresh issue towards:

• Repayment/ prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of its material subsidiaries, namely, Manipal Hospitals Private Limited
•  Acquisition of minority stake in its stepdown Subsidiary, Sahyadri Hospitals Private Limited
• General corporate purposes.

About Manipal Health Enterprises Limited

Manipal Health Enterprises operates one of India's largest pan-India multispecialty hospital networks, with 49 hospitals and 13,037 licensed beds across 14 states and union territories as of March 31, 2026. It is the largest private hospital chain by bed capacity and the second largest by number of hospitals in India. In Fiscal 2026, it served 7.63 million patients and had 11,064 doctors across its network.

The company specializes in tertiary and quaternary care, with cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences (CONGO-R) contributing 64.3% of gross inpatient revenue in Fiscal 2026. It has expanded through acquisitions, including AMRI Hospitals, Medica Synergie, and Sahyadri Group, and plans to add approximately 2,426 licensed beds by 2030.

Key Financial Highlights 

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.   

To read the RA disclaimer, please click here